1 – 50 of 125
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
The basal forebrain cholinergic system as target for cell replacement therapy in Parkinson's disease
(
- Contribution to journal › Scientific review
-
Mark
The history and status of dopamine cell therapies for Parkinson's disease
2024) In BioEssays(
- Contribution to journal › Scientific review
-
Mark
The annotation of GBA1 has been concealed by its protein-coding pseudogene GBAP1
(
- Contribution to journal › Article
- 2023
-
Mark
Restorative cell and gene therapies for Parkinson's disease
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
LINE-1 retrotransposons drive human neuronal transcriptome complexity and functional diversification
(
- Contribution to journal › Article
-
Mark
Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson's disease, STEM-PD
(
- Contribution to journal › Article
- 2022
-
Mark
Hunting out the autophagic problem in Huntington disease
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Single-cell transcriptional and functional analysis of dopaminergic neurons in organoid-like cultures derived from human fetal midbrain
(
- Contribution to journal › Article
-
Mark
The need for a standard for informed consent for collection of human fetal material
(
- Contribution to journal › Article
-
Mark
Age-related pathological impairments in directly reprogrammed dopaminergic neurons derived from patients with idiopathic Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Distinct subcellular autophagy impairments in induced neurons from patients with Huntington's disease
(
- Contribution to journal › Article
- 2021
-
Mark
Stem Derived Dopamine Neurons : Will They Replace DBS as the Leading Neurosurgical Treatment for Parkinson's Disease?
(
- Contribution to journal › Article
-
Mark
A quantitative model of cellular decision making in direct neuronal reprogramming
(
- Contribution to journal › Article
-
Mark
Reprogramming human adult fibroblasts into GABAergic interneurons
(
- Contribution to journal › Article
- 2020
-
Mark
Animal Models of Parkinson's Disease : Are They Useful or Not?
(
- Contribution to journal › Scientific review
-
Mark
3D-Printed Soft Lithography for Complex Compartmentalized Microfluidic Neural Devices
(
- Contribution to journal › Article
-
Mark
Longitudinal functional connectivity changes related to dopaminergic decline in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
GDNF and Parkinson's Disease : Where Next? A Summary from a Recent Workshop
(
- Contribution to journal › Article
-
Mark
Parkinson’s disease laterality : a 11C-PE2I PET imaging study
2020) In Journal of Neurology(
- Contribution to journal › Article
- 2019
-
Mark
Dual modulation of neuron-specific microRNAs and the REST complex promotes functional maturation of human adult induced neurons
(
- Contribution to journal › Article
-
Mark
Exploring causality of the association between smoking and Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Designing stem-cell-based dopamine cell replacement trials for Parkinson’s disease
(
- Contribution to journal › Article
- 2018
-
Mark
New approaches for brain repair-from rescue to reprogramming
(
- Contribution to journal › Scientific review
-
Mark
Simple Generation of a High Yield Culture of Induced Neurons from Human Adult Skin Fibroblasts
(
- Contribution to journal › Article
-
Mark
Dermal fibroblasts from patients with Parkinson's disease have normal GCase activity and autophagy compared to patients with PD and GBA mutations
(
- Contribution to journal › Article
-
Mark
11C-PE2I and 18F-Dopa PET for assessing progression rate in Parkinson's : A longitudinal study
(
- Contribution to journal › Article
-
Mark
Huntingtin Aggregation Impairs Autophagy, Leading to Argonaute-2 Accumulation and Global MicroRNA Dysregulation
(
- Contribution to journal › Article
- 2017
-
Mark
Human Trials of Stem Cell-Derived Dopamine Neurons for Parkinson's Disease : Dawn of a New Era
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
GFORCE-PD still going strong in 2016
(
- Contribution to journal › Scientific review
-
Mark
Direct neuronal reprogramming for disease modeling studies using patient-derived neurons : What have we learned?
(
- Contribution to journal › Scientific review
-
Mark
Neuroendocrine abnormalities in Parkinson's disease
(
- Contribution to journal › Scientific review
-
Mark
REST suppression mediates neural conversion of adult human fibroblasts via microRNA-dependent and -independent pathways
(
- Contribution to journal › Article
- 2016
-
Mark
Making it personal : the prospects for autologous pluripotent stem cell-derived therapies
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Exogenous melatonin for Parkinson's disease: 'Waking up' to the need for further trials
(
- Contribution to journal › Letter
-
Mark
Advancing pharmacotherapy for treating Huntington's disease : a review of the existing literature
(
- Contribution to journal › Article
-
Mark
The neurology community mourns the passing of Dr. John F. Kurtzke
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
A simple assessment model to quantifying the dynamic hippocampal neurogenic process in the adult mammalian brain
(
- Contribution to journal › Article
-
Mark
Learning to be inflexible : Enhanced attentional biases in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Hippocampal dysfunction defines disease onset in Huntington's disease
(
- Contribution to journal › Article
-
Mark
Time on timing : Dissociating premature responding from interval sensitivity in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Are Stem Cell-Based Therapies for Parkinson's Disease Ready for the Clinic in 2016?
(
- Contribution to journal › Article
-
Mark
Characterization and Visualization of Vesicles in the Endo-Lysosomal Pathway with Surface-Enhanced Raman Spectroscopy and Chemometrics
(
- Contribution to journal › Article
-
Mark
Aberrant nigral diffusion in Parkinson's disease : A longitudinal diffusion tensor imaging study
(
- Contribution to journal › Article
-
Mark
Different decision deficits impair response inhibition in progressive supranuclear palsy and Parkinson's disease
(
- Contribution to journal › Article
-
Mark
α-Synuclein pre-formed fibrils impair tight junction protein expression without affecting cerebral endothelial cell function
(
- Contribution to journal › Article
-
Mark
Comparative epidemiology of incident Parkinson's disease in Cambridgeshire, UK
(
- Contribution to journal › Article
-
Mark
Gray and white matter imaging : A biomarker for cognitive impairment in early Parkinson's disease?
(
- Contribution to journal › Article
-
Mark
Hypothalamic volume loss is associated with reduced melatonin output in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Increased serotonin-to-dopamine transporter ratios in Parkinson disease dyskinesias: a longitudinal study
(
- Contribution to conference › Abstract
-
Mark
Regional expression of the MAPT gene is associated with loss of hubs in brain networks and cognitive impairment in Parkinson disease and progressive supranuclear palsy
(
- Contribution to journal › Article